Table 1 Demographic and clinical characteristics
|  | All (n = 40) | BCI (n = 19) | Control (n = 21) |
|---|---|---|---|
Age, years, (SD) | 56 (13) | 56 (14) | 57 (11) |
Gender: male | 25 (62%) | 11 (44%) | 14 (56%) |
Days post stroke (SD) | 33 (14) | 31(10) | 34 (16) |
Stroke type: infarction/hemorrhage/both | 13/25/2 | 8/11/0 | 5/14/2 |
Stroke location | |||
 Cortical | 13 | 6 | 7 |
 Cortical and subcortical | 5 | 2 | 3 |
 Subcortical | 20 | 10 | 10 |
 Brainstem | 2 | 1 | 1 |
Stroke severity | |||
 NIHSS (SD) | 15.9 (4.9) | 15.1 (2.7) | 15.9 (4.9) |
 Scandinavian Stroke Scale (SD) | 24.0 (8.6) | 25 (6) | 23 (11) |
 Hemiparetic side, left | 25 (62.5%) | 11 (57.9%) | 14 (66.7%) |
 Dominant side affected | 14 (35%) | 7 (36.8%) | 7 (33%) |
 Able to move hand at onset | 0 | 0 | 0 |
 Able to walk at onset | 0 | 0 | 0 |
 Modified Rankin scale at baseline | 4 (4/4) | 4 (4/4) | 4 (4/4) |
 ARAT score at baseline median (IQR) | 0 (0) | 0 (0) | 0 (0) |
 FMA score at baseline median(Q1–Q3) | 4 (2/4) | 4 (2/4) | 4 (2/4) |
 FIM score at baseline median (Q1–Q3) | 47 (38/57) | 43 (38/51) | 47 (36/66) |
 Neglect present at enrolment, n (%) | 8 (21%) | 5 (27.8%) | 3 (15.0%) |
 MEP+/MEP− (n = 32) | 18/14 | 8/6 | 6/12 |